Abstract / Summary
This case series examines viral suppression outcomes among patients with HIV with prior adherence challenges, treatment experience, and resistance initiating lenacapavir and cabotegravir.
Topics
HIV/AIDS drug development and treatmentOpen access
Primary Source
JAMA Network Open